MedTrace Logo

TARGET Registry A Project of the German Network for Intestinal Diseases in Cooperation With Other Corporate Partners

NCT04031482 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 4400

Last updated 2019-07-29

No results posted yet for this study

Summary

By capturing possible or known risk factors, it will be possible to recognize connections between these risk factors and the disease, thus obtaining valuable insights into the cause of the disease. This in turn facilitates an improved evaluation of the treatment situation as well as influencing future framework conditions for preventive measures and planning treatments. Disease registries are thus crucial for the planning and structuring of health policies.

The present registry protocol serves as a basis for the proper implementation of a registry for patients with chronic inflammatory bowel diseases. It describes the study rationale, objectives, design, participant groups, procedures and evaluation methods. Furthermore, it defines the responsibilities of each person involved in maintaining the registry and also forms the basis for decisions regarding evaluation by the Ethics Committee.

Conditions

Interventions

OTHER

No intervention, only standard care

The aim of this registry is to expand on previous findings in the field of diagnostic and therapeutic pathways for patients with Crohn's disease, ulcerative colitis and indeterminate colitis undergoing routine administration of a targeted therapy (biologics or another targeted therapy such as Janus kinase therapy) and various different treatment approaches. A data pool is to be generated for this purpose, in order to * analyse disease progression * systematize findings about treatment processes * identify potential influencing factors * review any new diagnostic procedures * identify potential test subjects for further study * evaluate the safety of various treatment concepts

Sponsors & Collaborators

  • Ced Service GmbH

    lead OTHER

Principal Investigators

  • Sandra Plachta-Danielzik, PD Dr. · Kompetenznetz Darmerkrankungen

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-10-31
Primary Completion
2022-09-30
Completion
2023-09-30

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04031482 on ClinicalTrials.gov